US Pharma MarketingInvestors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.
HistoSonics seeks FDA de novo authorization in kidney cancer
Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.
Source: MedTech Dive